CertiScan® GMP/GCP Cloud: Dose-Level Lifecycle Data, Analytics, IRT, Reconciliation

IMC sets new clinical research standard with CertiScan® 2.0 end-to-end medication adherence analytics, disrupting smart device marketplace with customer-friendly ROI-driven data plans.

IMC now offers their GxP hardware, software and CertiScan® services as a subscription model, eliminating the final barrier to adapting smart dose analytics in clinical research: cost and supply management.

CertiScan® 2.0 is a vertically integrated SaaS, where GMP (devices) meet GCP (data and analytics). Stan Kachnowski PHD MPA, Executive Director of HITLAB calls CertiScan 2.0 “perhaps the biggest improvement to clinical research processes since barcodes became mandatory for clinical supplies 20 years ago; a truly disruptive solution sure to strengthen results from crucial clinical investigations”.

“The ultimate goal is to make Clinical research faster and less expensive. The ROI on our approach is tremendous; we call it the $100 Million opportunity for clinical trials” says Joanne Watters, Director of Global Customer Support at the recent Global Clinical Supplies Conference.